Senior Consultant

Diann Blanset, PhD, DABT

Dr. Diann Blanset is a Board-certified toxicologist with over 35 years of experience leading nonclinical safety programs for small molecule, biological and viral based products in various therapeutic areas, including oncology, respiratory, inflammation and infectious diseases. She is a recognized expert in viral vector-based products and reproductive toxicology for biologics, having published several manuscripts in these areas. Over her impressive career, she has contributed to the development of numerous new biological entities, including approved biologics for inflammatory diseases and several novel immunomodulators for oncology.

Prior to joining Akkeri, Diann was a Highly Distinguished Research Fellow at Boehringer Ingelheim responsible for the nonclinical development of a variety of programs over approximately 15 years. Previously, she served as the of Senior Director of Preclinical Development at Medarex, and held positions at Enzon, Roberts Pharmaceuticals and Huntingdon Life Sciences. She is an active member of BIO, having served as their representative on the ICH S5(R3) Expert Working Group and the BioSafe Leadership Committee. Diann is also a member of the Society of Toxicology and the American College of Toxicology. She received a B.A. and M.S. from Rutgers University and a Ph.D from the University of Medicine and Dentistry of New Jersey.